NCT00190788View on ClinicalTrials.gov

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

May 31, 2007

Conditions
SepsisHypotension
Interventions
DRUG

Drotrecogin Alfa (Activated)

DRUG

placebo

Trial Locations (2)

75679

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Paris

92350

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Loma Linda

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00190788 - Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion | Biotech Hunter | Biotech Hunter